US Patent Issued to H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE on Sept. 15 for "Delta opioid receptor antagonists reprogram immunosuppressive microenvironment to boost immunotherapy" (Washington, Florida Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,168, issued on Sept. 15, was assigned to H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.).

"Delta opioid receptor antagonists reprogram immunosuppressive microenvironment to boost immunotherapy" was invented by James Bianco (Seattle) and Paulo Rodriguez (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions and methods for mediating immunosuppressive myelopoiesis. Additionally, disclosed herein are combination therapies for treating cancers and methods of using the same."

The patent was filed on March 16, 2021, under Application No. 17/912,300.

*For further information, including images, charts...